Eine schwache Bayer-Aktie hat den DAX am Montag ins Minus gedrückt. Der deutsche Leitindex ging am Ende mit einem Vlerust…
Pfizer (PFE) reports mixed fourth-quarter 2023 results. It re-affirms its 2024 sales and earnings guidance provided in December 2023.…
Aside from a cavalcade of earnings, Case-Shiller came in lower month over month and JOLTS are out after the open.…
…
The global Lidocaine Hydrochloride Market size and share is currently valued at USD 512.70 million in 2023. It is anticipated…
Investor focus is likely to be on the sales numbers of Pfizers (PFE) several newly launched drugs like Abrysvo, Velsipity,…
Pfizer stock has dropped about 50% from its peak.…
Pfizer stock has dropped about 50% from its peak.…
Tuesday features earnings reports from Pfizer, General Motors, Microsoft, Alphabet, Starbucks and AMD while Apple, Amazon and Meta report Thursday.…
Pfizer Inc. (NYSE: PFE) is expected to release earnings results for its fourth quarter, before the opening bell on Jan.…
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer nach einem milliardenschweren Zukauf von 35 auf 29…
Leading recombinant proteins market players include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, GenScript Biotech Corporation, AbbVie Inc.,…
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer nach einem milliardenschweren Zukauf von 35 auf 29…
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs Global Market Report 2024" report has been added…
Dont write off this big pharma stock because of its current woes.…
…
Dont write off this big pharma stock because of its current woes.…
Pfizer shares have slipped in the double digits over the past year.…
Pfizers (PFE) revenues are expected to have declined in the fourth quarter of 2023 due to a steep decline in…
Im US-amerikanischen Wertpapierhandel ist das Wertpapier von Pfizer derzeit unauffällig. Zuletzt zahlten Investoren für das Papier 28,27 US-Dollar. Kaum auffällig…
…
…
During 2023, we have witnessed several significant business deals involving Antibody-drug conjugates (ADC), both in preclinical and clinical phase. This…
Pfizer stock is fresh off the lowest price levels shareholders have seen in a decade. Why is PFE stock so…
…
There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.…
Der Anteilsschein von Pfizer notiert heute ein wenig fester. Das Papier kostete zuletzt 28,29 US-Dollar. Am US-amerikanischen Aktienmarkt hat sich…
Pfizer Insider Convicted in High-Stakes Covid Pill Trading Scandal…
A former Pfizer Inc. employee was convicted of using confidential information about the company’s Covid-19 treatment to make illegal options…
…
Der BioTech-Sektor - Der Auftakt lässt noch zu wünschen übrig Der Jahresstart im Sektor Biotechnologie konnte bislang nicht begeistern. Seitwärts…
Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss…
Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the…
David Dietze, senior investment strategist of Peapack Private Wealth Management, tells Quartz why Pfizer, Exxon, and Walgreens could be great…
…
Antiemetics drugs market size from USD 3.1 billion in 2022 to USD 5.4 billion in 10 years. The rising prevalence…
…
Pfizers best days might be behind it as demand for its COVID-19 products hits a wall.…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
Pfizer shares dropped more than 40% last year.…
…
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Womens Health Market Size, Share & Trends Analysis Report…
Stocks Analysis by MarketBeat.com (Kate Stalter) covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, Bristol-Myers Squibb Company.…
Stocks Analysis by MarketBeat.com (Jea Yu) covering: Novartis AG, Vertex Pharmaceuticals Inc, Biogen Inc, Pfizer Inc. Read MarketBeat.com (Jea Yu)s…
Frankfurt (Reuters) - Nach dem Ende des Corona-Booms setzt Biontech in den kommenden Jahren verstärkt auf seine Krebsforschung.
"Aktuell laufen…
…
The stock looks cheap, but it does come with risks.…
The stock looks cheap, but it does come with risks.…
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Treatment Market - Global Industry Analysis, Size,…
…